33 results

• Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month

  April 21, 2026

  Irvin Jackson

  A group of federal judges will determine whether all Dupixent cancer lawsuits should be formed into a multidistrict litigation, following oral arguments set for May 28.

• Dupixent Injections Caused Peripheral T-Cell Lymphoma (PTCL) Diagnosis: Lawsuit

  April 6, 2026

  Irvin Jackson

  An Illinois man's Dupixent injection lawsuit claims manufacturers knew, or should have known, about the potential T-cell cancer risks, but hid those problems from the public.

• Link Between Dupixent and CTCL Withheld From Users, Medical Community: Lawsuit

  March 31, 2026

  Irvin Jackson

  A Dupixent lawsuit indicates the manufacturers failed to warn doctors and patients about the risks of T-cell lymphoma and other forms of cancer.

• Drug Makers Agree Dupixent Cancer Lawsuits Should Be Centralized in MDL

  March 26, 2026

  Irvin Jackson

  Regeneron and Sanofi-Aventis agree with calls to consolidate all Dupixent cancer lawsuits currently spread throughout the federal court system before one judge.

• Enlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims

  March 16, 2026

  Irvin Jackson

  The makers of Dupixent face a lawsuit from a Florida woman who says she developed CTCL after just a month of injections of the atopic dermatitis treatment.

• Dupixent Mycosis Fungoides Lawsuit Filed Over Failure To Warn About T-Cell Lymphoma Risks

  March 9, 2026

  Irvin Jackson

  A Georgia couple's lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma.

• Dupixent Caused T-Cell Lymphoma or Rapidly Progressed Cancer, Lawsuit Alleges

  February 25, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit indicates that not only did the drug make his eczema worse, it also caused him to develop late-stage T-cell lymphoma.

• MDL Sought for Dupixent Lymphoma Lawsuits Filed in Federal Courts Nationwide

  February 19, 2026

  Irvin Jackson

  A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.

• Lawsuit Claims Dupixent for Atopic Dermatitis, Eczema Treatment Caused CTCL

  February 10, 2026

  Irvin Jackson

  The manufacturers of Dupixent are facing a product liability lawsuit from a man who alleges the eczema drug caused him to develop a rare form of cancer.

• CTCL Diagnosis Leads to Lawsuit Over Dupixent Cancer Risks

  February 3, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit indicates that manufacturers knew of the risks of CTCL, yet failed to report them to patients or doctors.